Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

Wow, game-changing data out at !

Sema 2.4mg ⬇️ CVd+HF events by 21% in HF subgroup of n=4,286

Remarkably, efficacy & safety consistent in both HFrEF & HFpEF

Supports health status gains in & likely to have regulatory/guideline implications

Wow, game-changing #SELECT data out at #HeartFailure2024!

Sema 2.4mg ⬇️ CVd+HF events by 21% in HF subgroup of n=4,286

Remarkably, efficacy & safety consistent in both  HFrEF & HFpEF

Supports health status gains in #STEPHFpEF & likely to have regulatory/guideline implications
account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

May held some of the biggest heart failure, interventional, & electrophysiology cardiology meetings!

Explore the hottest science from at 2024 , , & here: bit.ly/3QYbx3d

May held some of the biggest heart failure, interventional, & electrophysiology cardiology meetings!

Explore the hottest science from #JACCJourals at #HeartFailure2024, #EuroPCR, & #HRS2024 here: bit.ly/3QYbx3d

#HeartFailure #EPeeps #cvEP #CathLab
account_circle
CSANZ(@thecsanz) 's Twitter Profile Photo

Check out the highlights in Heart Failure for in Perth - early-bird closing Monday 3 June. Watch video👉bit.ly/3R3AVod
Register Now!👉csanzasm.com
David Playford Dr Girish Dwivedi

Check out the highlights in Heart Failure for #CSANZ2024 in Perth - early-bird closing Monday 3 June. Watch video👉bit.ly/3R3AVod
Register Now!👉csanzasm.com 
#CardioTwitter @PlayfordDavid @cardiacimager  #heartfailure2024
account_circle
Área del Corazón del HUVV de Málaga(@ACorazonHUVV) 's Twitter Profile Photo

👩‍⚕️Nuestra residente, Lucía Palma, presenta el trabajo: Clinical, prognosis and economic outcomes in a novel cardio-renal-metabolic unit en

👩‍⚕️Nuestra residente, Lucía Palma, presenta el trabajo: Clinical, prognosis and economic outcomes in a novel cardio-renal-metabolic unit en #HeartFailure2024
account_circle
Ahmed Bennis(@drbennisahmed) 's Twitter Profile Photo



CD8+ Cytotoxic T-cells Drive Outcome in Chronic Inflammator Cardiomyopathy

unexplored role of CD8+ T-cells in InfI-CMP

Selectively targeting the CD8+ T-cell population may further benefit the treatment of Infl-CMP patients

#HeartFailure2024

CD8+ Cytotoxic T-cells Drive Outcome in Chronic Inflammator Cardiomyopathy

unexplored role of CD8+ T-cells in InfI-CMP

Selectively targeting the CD8+ T-cell population may further benefit the treatment of Infl-CMP patients
account_circle
Ahmed Bennis(@drbennisahmed) 's Twitter Profile Photo


EXCELLENT Phase 1/2b study: ProtheraCytes® cell therapy in Acute Myocardial Infarction

Regenerative therapy based on ProtheraCytes® injection in post-AMI emerges as innovative strategy to prevent heart failure-associated outcomes
Javed Butler C. Michael Gibson MD

#HeartFailure2024
EXCELLENT Phase 1/2b study: ProtheraCytes® cell therapy in Acute Myocardial Infarction

Regenerative therapy based on ProtheraCytes® injection in post-AMI emerges as innovative strategy to prevent heart failure-associated outcomes
@JavedButler1 @CMichaelGibson
account_circle
Ahmed Bennis(@drbennisahmed) 's Twitter Profile Photo



PRAISE HFpEF DM
Glucagon-like Peptide-1 Receptor Agonist In obeSE Heart Failure with Preserved Ejection Fraction with type 2 diabetes

In DM and obese HFpEF, GLP1-RA at diabetes management associated with reduction in the composite of HFH and mortality

#HeartFailure2024

PRAISE HFpEF DM
Glucagon-like Peptide-1 Receptor Agonist In obeSE Heart Failure with Preserved Ejection Fraction with type 2 diabetes

In DM and obese HFpEF, GLP1-RA at diabetes management associated with reduction in the composite of HFH and mortality
account_circle
Novi Tham(@slumberbell) 's Twitter Profile Photo

Beautiful from my lens 📸,
Which one is your fave?😊

1️⃣ Rua da Bica de Duarte Belo
2️⃣ Calçada de Sant’Ana
3️⃣ Belém Tower
4️⃣ Alfama

Beautiful #Lisbon from my lens 📸,
Which one is your fave?😊

1️⃣ Rua da Bica de Duarte Belo
2️⃣ Calçada de Sant’Ana
3️⃣ Belém Tower
4️⃣ Alfama

#HeartFailure2024
account_circle
David Couto Mallón(@david_cm_) 's Twitter Profile Photo

Aficamten for the treatment of symptomatic oHCM. A new kid in the block showing significant improvement in symptoms, exercise capacity and quality of life compared to placebo in oHCM patients 👏🏻👏🏻👏🏻 European Society of Cardiology

Aficamten for the treatment of symptomatic oHCM.  A new kid in the block showing significant improvement in symptoms, exercise capacity and quality of life compared to placebo in oHCM patients 👏🏻👏🏻👏🏻#HeartFailure2024 #sequoia_hcm @escardio
account_circle
Ahmed Bennis(@drbennisahmed) 's Twitter Profile Photo



Diuresis Efficacy in Ambulatory Chronic Heart Failure Patients:
Intra-Patient Comparison of Three Diuretic Regimens (DEA-HF Clinical Trial)

Intravenous furosemide plus metolazone resulted in a significantly higher natriuresis when compared to IV furosemide

#HeartFailure2024

Diuresis Efficacy in Ambulatory Chronic Heart Failure Patients:
Intra-Patient Comparison of Three Diuretic Regimens (DEA-HF Clinical Trial)

Intravenous furosemide plus metolazone resulted in a significantly higher natriuresis when compared to IV furosemide
account_circle
Novi Tham(@slumberbell) 's Twitter Profile Photo

Should we ablate rEF / pEF patients with

Pro⚠️:
📍 ablation ➡️ 📉likelihood of death & surgical interventions in px
📍📉all cause& death after ablation
📍⬆️improve fx and ⬇️ burden
📍benefit >> in high risk px

Should we ablate #HFrEF / #HFpEF patients with #AFib❓#EPeeps 

Pro⚠️:
📍#AFib ablation ➡️ 📉likelihood of death & surgical #HF interventions in #HF px
📍📉all cause& #CV death after ablation
📍⬆️improve #LV fx and ⬇️#AFib burden
📍benefit >> in high risk px

#HeartFailure2024
account_circle
Jozine ter Maaten(@jozinetm) 's Twitter Profile Photo

📣 First from : Timing of cardio-kidney protection with inhibitors ⏰
⭐️ across cardio kidney cohorts HF hospitalization presents an early and modifiable event with SGLT2
ahajournals.org/doi/abs/10.116…

📣 First #LBCT from #HeartFailure2024: Timing of cardio-kidney protection with #SGLT2 inhibitors ⏰
⭐️ across cardio kidney cohorts HF hospitalization presents an early and modifiable event with SGLT2 
ahajournals.org/doi/abs/10.116…
account_circle
Alexandra Henry (Gamard)(@agamard_esc) 's Twitter Profile Photo

Straight out of , it’s time to launch the JOURNAL CLUB

1st edition is on 5 JUNE 6PM CEST will discuss: the PUSH-AHF trial

Register now: bit.ly/44J2jxw

Straight out of #HeartFailure2024, it’s time to launch the #HFA_ESC #HFA_YOUNG JOURNAL CLUB 

1st edition is on 5 JUNE 6PM CEST will discuss: the PUSH-AHF trial 

Register now: bit.ly/44J2jxw
account_circle